Rishi Singh, M.D.
| Appointed: |
2005 |
| Gender: |
Male |
| Languages: |
English |
Ophthalmology
Biographical Sketch
Rishi Singh, MD, is an Associate Staff Member in the Department of Ophthalmology at Cleveland Clinic’s main campus. His specialty interests include medical and surgical retina and diabetic retinoplasty.
He earned his medical degree from Boston University School of Medicine in Boston, Mass. He completed an internship at Lemuel Sattuck Hospital in Boston and a residency at the Massachusetts Eye and Ear Infirmary, also in Boston. He completed a vitreoretinal fellowship at the Cole Eye Institute of the Cleveland Clinic in Cleveland, Ohio.
Dr. Singh has published a number of articles in peer-reviewed journals. He has also lead clinical trials looking at the treatment of diabetic macular edema, central retinal vein occlusions and age-related macular degeneration.
Education & Fellowships
| Medical School: | Boston University School of Medicine, Boston, MA |
|
| Internship: | Lemuel Shattuck Hospital, Transitional, Boston, MA |
| Residency: | Massachusetts Eye and Ear Infirmary, Ophthalmology, Boston, MA |
| Fellowship: | Cleveland Clinic, Vitreoretinal, Cleveland, OH |
| Other Education: | (Undergraduate) Boston University, Boston, MA |
Certifications
Specialty Interests
Diabetic retinopathy, emphasis on treating conditions such as age-related macular degeneration, macula and vitreous, Retinal Detachment, Surgical and medical treatment of the retina.
Awards & Honors
• Fellow Teaching Award
• Alpha Omega Alpha Research Award
• International Medical Congress Research Achievement Award
• American Association of Physicians of Indian Origin Research Award
• Research to Prevent Blindness Fellowship
• National Institutes of Health/American Association of Medical Colleges Basic Science Research Award
Professional Memberships
- American Academy of Ophthalmology
- Association of American Retinal Specialists
Specializes in Diseases and Conditions
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 10/6/2008, Dr. Singh has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
Consulting. Dr. Singh receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
- Alcon Laboratories
- Oraya Therapeutics
- WebMD Inc.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
